TP53 and triple-negative breast carcinoma: Furthermore, Di Gennaro et al. [36,37] showed that high endogenous miR-30a expression was associated with improved survival of triple-negative breast cancer patients, and validated miR-30a as a direct target of p53 transcriptional activity.